Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
Phase of Trial: Phase II
Latest Information Update: 23 Jul 2019
Price : $35 *
At a glance
- Drugs Dasatinib (Primary) ; Erlotinib (Primary) ; Everolimus (Primary)
- Indications Glioma
- Focus Therapeutic Use
- Acronyms BIOMEDE
- 14 Feb 2019 Planned number of patients changed from 250 to 315.
- 31 Aug 2018 Biomarkers information updated
- 18 Feb 2015 Planned number of patients changed from 225 to 250 as reported by ClinicalTrials.gov record.